Abiraterone effectively attenuates the upregulation of DHEA production in glioblastomas, and obviously impairs SAR1-mediated protein processing, leading to the initiation of ER stress, ROS accumulation, and apoptosis. This evidence concerns the gene SAR1A and glioblastoma.